The Luxury Collection® Hotels & Resorts Unveils Transformed Pine Cliffs Resort
The Luxury Collection® Hotels & Resorts, part of Starwood Hotels & Resorts Worldwide, Inc. (NYSE:HOT), today announced the official re-opening of Pine Cliffs Hotel, a Luxury Collection Resort, Algarve. Owned by United Investments Portugal, the celebrated cliff-top retreat recently emerged from an all-encompassing 18 month renovation which restored the award-winning Pine Cliffs Hotel, alongside the addition of the new contemporary Pine Cliffs Ocean Suites. Together with Pine Cliffs Residence, the complex sits at the heart of Portugal’s burgeoning luxury travel scene, further cementing the destination’s appeal to sophisticated, discerning travellers. This is the latest treasure to be unveiled by The Luxury Collection as part of a multi-million dollar investment to restore the brand’s most iconic hotels around the world.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160705005478/en/
Starwood Hotels & Resorts - Pine Cliffs Ocean Suites, a Luxury Collection Resort- Facade (Photo: Business Wire)
“The spectacular transformation of the iconic Pine Cliffs is testament to the collaborative and longstanding relationship we enjoy with United Investments Portugal,” said Michael Wale, President, Starwood Hotels & Resorts, Europe, Africa and Middle East. “This is without a doubt one of Starwood’s most significant developments this year, and ensures this very special resort firmly remains the definitive luxury destination in the Algarve for generations to come.”
Reimagined by acclaimed designer Lynne Hunt, all 217 guestrooms and suites, public areas and facilities have gone through extensive renovations. The completely transformed resort evokes Pine Cliffs’ Portuguese heritage with historic features such as the hotel’s cherished azulejos - traditional hand-painted tiles that were fired in the kilns of Lisbon’s Fábrica de Cerâmica Constância - as lavish, one-of-a-kind headboards in every room. Grand panels recounting the discoveries of Vasco de Gama and Ferdinand Magellan, as well as a detailed map reproduction of the Mediterranean by famed medieval cartographer Giorgio Sideri, adorn the walls of the lobby while classic touches like terracotta floors can be found throughout the resort.
Spanning over 170 acres across the Algarve coastline, the resort boasts 11 different restaurants and bars under the supervision of Executive Chef Marco Alban, including the poolside seafood restaurant O Pescador; Beach Club on the golden shore of Praia da Falésia; Piri Piri Steak House; and Zest, a new outlet offering guests an array of health-conscious drinks, snacks and dishes.
One of the most alluring additions is Pine Cliffs’ highly anticipated new state-of-the-art destination spa, Serenity The Art of Well Being – an unrivalled 10,000 square foot haven of inspired indigenous and holistic wellness experiences that will firmly place Portugal on the radar of discerning spa connoisseurs. In addition, the hotel offers six swimming pools, Porto Pirata, the region’s largest kids club, an Annabel Croft Tennis Academy, a nine-hole golf course with panoramic views, expansive gardens, numerous shops and boutiques, and over 23,000 square feet of event and meeting space.
“Pine Cliff’s renovation truly is a cornerstone in The Luxury Collection brand’s investment effort to renovate some of the most iconic hotels around the globe,” said Meredith Dichter, Global Brand Director, The Luxury Collection Hotels & Resorts. “We are thrilled to deliver enhanced accommodations in the Algarve, a perennial favorite of global explorers, to our guests.”
Alongside the hotel in a striking cliff-top location, the new Pine Cliffs Ocean Suites comprise 148 suites, one- and two-bedroom luxury apartments complete with personalized butler service and full access to all of Pine Cliffs’ facilities.
“We are delighted to strengthen our successful partnership with Starwood Hotels & Resorts, which over the past 24 years saw Pine Cliffs be established as the leading resort in Portugal and one of the finest in Europe,” said Carlos Leal, General Manager, United Investments Portugal. “We are very proud to preserve the distinctive indigenous DNA of this iconic hotel, while at the same time revitalising it and creating a new benchmark for luxury seafront living in Portugal with the introduction of the new Pine Cliffs Ocean Suites.”
Rates for Pine Cliffs Hotel, a Luxury Collection Resort, start from $165 per night. Prices for the new Pine Cliffs Ocean Suites, a Luxury Collection Resort, start from $250 per night (all prices quoted are valid for stays between 16 Sept. 2016 to 30 June 2017). For further information and reservations please visit LUXURYCOLLECTION.COM/ALGARVE or LUXURYCOLLECTION.COM/PINECLIFFSOCEANSUITES.
About The Luxury Collection Hotels & Resorts
The Luxury Collection® brand is comprised of world-renowned hotels and resorts offering unique, authentic experiences that evoke lasting, treasured memories. For the global explorer, The Luxury Collection offers a gateway to the world's most exciting and desirable destinations. Each hotel and resort is a unique and cherished expression of its location; a portal to the destination's indigenous charms and treasures. Originated in 1906 under the CIGA® brand as a collection of Europe's most celebrated and iconic properties, today The Luxury Collection brand is a glittering ensemble, recently surpassing 100 of the world's finest hotels and resorts in more than 30 countries. All of these hotels, many of them centuries old, are internationally recognized as being among the world's finest. For more information and new openings, visit theluxurycollection.com or follow Twitter, Instagram and Facebook.
Simon Neggers, 212.380.4029
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Pierre Fabre & Array BioPharma Announce a 62% Observed OS at One Year from the Phase 3 BEACON CRC Safety Lead-In of the Combination of Encorafenib, Binimetinib and Cetuximab in BRAF-Mutant CRC at the ESMO GI Congress23.6.2018 11:00 | Pressemelding
Not intended for UK- and US-based media Pierre Fabre and its partner Array BioPharma Inc. today announced updated safety and efficacy results, including OS, from the safety lead-in of the Phase 3 BEACON CRC trial evaluating the triplet combination of encorafenib, a BRAF inhibitor, binimetinib, a MEK inhibitor and cetuximab, an anti-EGFR antibody, in patients with BRAF V600E -mutant metastatic colorectal cancer (CRC). The results showed that, at the time of analysis, the OS data were fully mature through 12.6 months and that the median OS had not yet been reached. The one-year overall survival rate for this cohort was 62%. These data were presented in an oral presentation on Saturday, June 23, at the ESMO 20th World Congress on Gastrointestinal Cancer in Barcelona, Spain. The median progression-free survival (mPFS) for patients treated with the triplet was 8 months [95% CI 5.6-9.3] and is similar between patients receiving one prior line of therapy and patients receiving two prior lines
Compelling Data for LONSURF® (trifluridine/tipiracil) in Metastatic Colorectal Cancer Presented at ESMO’s World Congress on Gastrointestinal Cancer by Servier and Taiho23.6.2018 08:10 | Pressemelding
Servier and Taiho Pharmaceutical Co., Ltd. today announced that the TASCO-1 trial demonstrated promising results for LONSURF® (trifluridine/tipiracil) in combination with bevacizumab in patients with previously untreated metastatic colorectal cancer (mCRC) who are not suitable for intensive treatment, with a median progression-free survival (PFS) of 9.2 months (ranging from 7.6 to 11.5 months). A second non-comparative arm in the trial, evaluated the outcome of patients treated with the current standard of care of capecitabine in combination with bevacizumab. The median PFS of this arm was 7.8 months (ranging from 5.5 to 10.1 months). “Colorectal cancer is the third most common cancer in the world. While there has been some progress in treatment, there are still few options for patients with metastatic disease who are not suitable for intensive treatment,” said Professor Eric Van Cutsem, Head of Digestive Oncology at the University of Leuven, Belgium. “These compelling results suggest
Softomotive and Accelerate RPA Partner to Help Enterprises Achieve Faster Time to Value from RPA22.6.2018 15:13 | Pressemelding
Softomotive, a world–class Robotic Process Automation (RPA) technology provider offering best time to value and affordability for all sizes and types of enterprises, is pleased to announce a strategic partnership with AccelerateRPA, a high calibre professional services provider of trained and certified RPA Consultants within Robotic Process Automation. This partnership means that customers and end users of Softomotive’s software, will have additional knowledgeable and professional guidance available to help achieve significant value quickly from their investment in RPA. Companies who are looking to implement Softomotive’s RPA product suite (WinAutomation and ProcessRobot software) will now have direct access to AccelerateRPA’s highly skilled consultants and Developers. Further, AccelerateRPA has also become a licensed reseller of Softomotive’s products, offering customers a single point of contact for delivering both RPA software and services. Ashley Hudson, Director of AccelerateRPA,
Ascend Performance Materials Announces Price Increase for Intermediate Materials22.6.2018 14:00 | Pressemelding
Ascend Performance Materials announced today a price increase for its intermediate materials. The price increase will take effect globally on July 1, 2018, and includes the following terms: Material Price Increase Terms Hexamethylene diamine (HMD) $0.17/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Acrylonitrile (AN) $0.20/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Customers should contact their local sales representative for additional information. About Ascend Performance Materials Ascend Performance Materials is a global premium provider of high-quality plastics, fibers and chemicals and is the world’s largest integrated producer of PA66 resin. Headquartered in Houston, Texas, Ascend has eight global locations, including five fully-integrated manufacturing facilities located in the southeastern United States, all dedicated to the innovation and safe production of nylon 6,6. With
Different Countries, Different Customs: Get Ready for the Motorbike Holidays with Moto-tyres.co.uk22.6.2018 13:41 | Pressemelding
Pack your bags, close the boot and get away on holiday? When you start your holidays on a motorcycle, you usually have to consider a few things more when getting ready for your trip. The right preparation is therefore a must. So that nothing stands in the way of a smooth journey, Moto-tyres.co.uk has put together some tips for your next trip. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180622005345/en/ Different countries, different customs: get ready for the motorbike holidays with Moto-tyres.co.uk (Photo: Business Wire) Whether a weekend trip or extended adventure, it all depends on the right equipment. Functional clothing, protectors and rain protection are a must on long trips. Wearing a suitable motorcycle helmet is a legal requirement almost everywhere. However, there are also very different rules and regulations for motorbike equipment and accessories depending on the destination, and you should familiarise yoursel
Boehringer Ingelheim bolsters biologics research and development with 230 million euro investment in new development center22.6.2018 12:00 | Pressemelding
Today Boehringer Ingelheim announced a 230 million euro investment into a new Biologicals Development Center (BDC) at the company’s Research and Development site in Biberach, Germany during the foundation stone laying for the new center. “The BDC is another key building block supporting the company’s long-term strategy for increasing the pipeline’s share of biologicals. This is particularly driven by two of our core areas, immune oncology and immunology,” says Dr. Fridtjof Traulsen, Corporate Senior Vice President Development at Boehringer Ingelheim. “The share of new biological entities in Boehringer Ingelheim’s research pipeline has been consistently increasing over the past few years and has now reached forty percent.” The BDC will help to maximize synergies by integrating biologicals analytical and process development as well as manufacturing for clinical studies into one seamless unit, while at the same time increasing development capacity. Following a staggered launch beginning i